Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands |
3 Months Ended |
Apr. 30, 2019 |
Apr. 30, 2018 |
| Cash used in operating activities |
|
|
| Net loss |
$ (12,064)
|
$ (6,579)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Depreciation and amortization |
470
|
383
|
| Amortization of deferred contract costs |
1,608
|
833
|
| Stock-based compensation |
4,812
|
3,157
|
| Bad debt expense |
281
|
32
|
| Changes in operating assets and liabilities: |
|
|
| Accounts receivable |
1,588
|
9
|
| Deferred contract costs |
(2,782)
|
(2,188)
|
| Prepaid expenses and other assets |
(1,635)
|
(2,274)
|
| Accounts payable |
(1,094)
|
(1,228)
|
| Accrued expenses and other liabilities |
124
|
(402)
|
| Accrued compensation |
(1,315)
|
598
|
| Deferred revenue |
2,441
|
3,349
|
| Net cash used in operating activities |
(7,566)
|
(4,310)
|
| Cash used in investing activities |
|
|
| Purchases of property and equipment |
(1,190)
|
(382)
|
| Net cash used in investing activities |
(1,190)
|
(382)
|
| Cash from financing activities |
|
|
| Proceeds from initial public offering, net of underwriters' discounts and commissions |
220,086
|
0
|
| Proceeds from issuance of common stock upon exercise of stock options |
2,240
|
306
|
| Proceeds from early exercised stock options, net of repurchases |
0
|
(7)
|
| Proceeds from repayment of promissory note |
515
|
0
|
| Payments of costs related to initial public offering |
(3,923)
|
0
|
| Net cash provided by financing activities |
218,918
|
299
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
210,162
|
(4,393)
|
| Cash, cash equivalents and restricted cash at beginning of year |
130,323
|
46,451
|
| Cash, cash equivalents and restricted cash at end of year |
340,485
|
42,058
|
| Supplemental cash flow data: |
|
|
| Cash paid for taxes |
2
|
12
|
| Non-cash investing and financing activities: |
|
|
| Vesting of early exercised options |
334
|
59
|
| Purchase of property and equipment, accrued but not yet paid |
1,253
|
279
|
| Costs related to initial public offering, accrued but not yet paid |
2,041
|
0
|
| Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets |
|
|
| Total cash, cash equivalents and restricted cash |
$ 130,323
|
$ 46,451
|